Abingdon Health
Abingdon Health is a British manufacturer of lateral flow assay diagnostic tests.[1] It is under contract to the British government for the supply of AbC-19 rapid antibody tests,[2] a test for the presence of IgG antibody against the SARS-CoV-2 spike protein,[3] as part of the UK Rapid Test Consortium program.[4] On 27 January 2021, the Financial Times reported that "all outstanding orders" had been cancelled by the Department of Health on 11 January 2021, following Abingdon's failure to obtain approval for home use of its lateral flow test by 25 December 2020.[5]
References
- ^ "Abingdon Health announces its latest expansion and additional manufacturing capacity". Lifescience Industry News. 2020-06-18. Retrieved 2020-11-12.
- ^ "Government invests in UK-developed antibody tests from UK Rapid Test Consortium". GOV.UK. Retrieved 2020-11-12.
- ^ Gill, Dipender; Ponsford, Mark J. (2020-11-11). "Testing for antibodies to SARS-CoV-2". BMJ. 371. doi:10.1136/bmj.m4288. ISSN 1756-1833.
- ^ Symon, Ken (2020-10-19). "Medical diagnostics company signs deal on delivery of Covid-19 tests". businessInsider. Retrieved 2020-11-12.
- ^ https://www.ft.com/content/272a4903-4a0c-4736-914a-ca5a4a51ba37
External links
 | This article about a company of the UK is a stub. You can help Wikipedia by expanding it. |
 | This article about a medical, pharmaceutical or biotechnological corporation or company is a stub. You can help Wikipedia by expanding it. |
 | This article about the COVID-19 pandemic is a stub. You can help Wikipedia by expanding it. |